AIM
CPXX

Acrospire Investment Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Acrospire Investment Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-932
Closed -$28K – 2342
2016
Q2 		$28K Buy
+932
New +$18.9K 0.02% 1425

Acrospire Investment Management's CPXX Position: Q3 2016 in Review

Acrospire Investment Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 932 shares — an estimated $28K sold.

Acrospire Investment Management first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $28K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Acrospire Investment Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 932 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $28K.
  • Acrospire Investment Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Acrospire Investment Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $28K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.